
First Choice Healthcare Solutions, Inc.
93
Recent news coverage includes general market and sector news but no direct recent developments specific to First Choice Healthcare Solutions, Inc.
- No direct recent business developments or announcements specific to First Choice Healthcare Solutions, Inc. were identified in the latest news sources [N1][N2][N3][N4][N5][N6][N7][N8].
First Choice Healthcare Solutions, Inc. is a Delaware corporation pivoting its business model from orthopedic and physical therapy services to developing a national network of innovative medical functional health and wellness clinics. These clinics focus on life improvement services including anti-aging, hormone replacement, weight management, and pharmacy services. The company operates through a centralized management structure with subsidiaries for clinic operations, property leases, and compounding pharmacy services. The provider staff primarily consists of Nurse Practitioners to improve care quality and margins. The company integrates personalized care plans with lab and genetic testing and offers both insured primary care and primarily self-pay quality-of-life services. The compounding pharmacy supports personalized medication fulfillment and plans geographic expansion of licensure and facilities. The company exited bankruptcy in 2022 and is led by CEO Lance Friedman. Financially, the company faces liquidity challenges with a low current ratio and reported net losses as of the latest quarter.
First Choice Healthcare Solutions, Inc. is transitioning from an orthopedic services provider to a national chain of medical functional health and wellness clinics offering personalized primary care and quality-of-life services. The company operates through subsidiaries managing clinics, leases, and a compounding pharmacy. Financially, as of September 30, 2026, the company reported a net loss of $10.68 million and liquidity ratios indicating significant current liabilities relative to assets. Financial figures are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice [S2].
The company's pivot to a national chain of medical functional health and wellness clinics addresses growing consumer demand for personalized, preventive, and quality-of-life healthcare services. Integration of a compounding pharmacy allows for tailored medication therapies, potentially enhancing patient outcomes and revenue margins. The use of Nurse Practitioners as primary providers may improve operational efficiency and cost structure. The acquisition of established clinic concepts and pharmacy operations provides a platform for expansion. The focus on self-pay services aligns with trends toward consumer-driven healthcare spending.
The company faces significant liquidity constraints with a current ratio of 0.01 and substantial current liabilities exceeding current assets, indicating financial stress. The transition away from legacy orthopedic services to a new business model involves execution risks, including competition from established providers and virtual clinics. The reliance on primarily self-pay quality-of-life services may limit patient uptake or require discounting, impacting revenue and profitability. The company’s recent emergence from bankruptcy and limited board governance may pose governance and operational risks. Market fragmentation and regulatory challenges in pharmacy licensure expansion add complexity to growth plans.
First Choice Healthcare Solutions leverages a vertically integrated model combining primary care clinics with an in-house compounding pharmacy, enabling personalized medication plans and enhanced patient experience. The focus on Nurse Practitioners for staffing offers cost advantages and quality care. The company's strategy to provide a broad suite of wellness and longevity services alongside traditional primary care differentiates it from competitors. However, the healthcare market is fragmented and competitive, with established virtual and brick-and-mortar providers offering overlapping services. The company's recent emergence from bankruptcy and ongoing liquidity challenges may limit its ability to capitalize fully on its integrated model in the near term.
• Liquidity Risk: The company has a current ratio of 0.01 as of September 30, 2026, indicating significant liquidity challenges with current liabilities far exceeding current assets.
• Execution Risk: Pivoting from orthopedic services to a national chain of wellness clinics requires successful integration of acquisitions, operational scaling, and market acceptance.
• Competitive Risk: The healthcare market is fragmented with competition from virtual providers, brick-and-mortar clinics, and specialized private practices offering overlapping services.
• Revenue Model Risk: The reliance on primarily self-pay quality-of-life services may result in fewer patients or the need to discount services, impacting revenue and profitability.
• Regulatory and Licensing Risk: Expansion of compounding pharmacy operations requires obtaining multiple state licenses and compliance with federal and state regulations, which may delay growth.
• Governance Risk: Recent board resignations and sole board member status may affect oversight and strategic decision-making until new members are appointed.
Business trends: Strategic pivot from orthopedic services to a national chain of personalized medical functional health and wellness clinics integrating primary care and compounding pharmacy services.
Execution milestones: Completion of acquisitions (Pointe Medical, LiveWell Drugstore, The Good Clinic), expansion of pharmacy licensure and facilities, and establishment of a new board.
Key risks: Liquidity constraints, competitive healthcare market, reliance on self-pay services, regulatory challenges in pharmacy expansion, and governance transition risks.
Very high visibility
Visibility score reflects the breadth and consistency of available disclosure across SEC filings, recent public reporting, and baseline business context (research-only; not investment advice).
- First Choice Healthcare Solutions, Inc. is pivoting from an orthopedic services business model to developing a national chain of medical functional health and wellness clinics focused on life improvement services such as anti-aging, weight management, hormone replacement, and pharmacy services in key U.S. markets [S1].
- The company plans to terminate all remaining legacy orthopedic and physical therapy services and focus resources on the new clinic strategy [S1].
- The corporate structure includes centralized management (Leading Primary Care, Inc.) and three operating subsidiaries: Live Well Medical Group (primary care clinics), The Good Clinic Properties, Inc. (clinic leases), and Live Well Drugstore, Inc. (compounding pharmacy operations) [S1].
- The company acquired Pointe Medical Services, Livewell MD, and Livewell Drugstore in 2023 and 2024 as part of its strategic pivot [S1].
- The Good Clinic, a primary care clinic concept specializing in whole person primary care and wellness, was acquired in an all-stock deal for $3.5 million [S1].
- The business model centers on personalized care plans based on individual health needs, including lab and genetic testing, with a provider staff primarily composed of Nurse Practitioners to improve margins and care quality [S1].
- Services offered include primary care reimbursed by commercial and government insurance, and a suite of quality-of-life services (anti-aging, hormone therapy, weight management, cosmetic dermatology, biohacking) that are primarily self-pay [S1].
- The company operates a USP 795 and 797 compliant compounding pharmacy (LiveWell Drugstore) with plans for physical expansion and administrative improvements, currently licensed in Florida, Georgia, and Mississippi, with plans to expand licensure [S1].
- The pharmacy supports personalized medication plans and aims to provide centralized fulfillment and delivery to clinics and patients, including sterile and non-sterile compounded medications [S1].
- The company faces competition from virtual providers, brick-and-mortar clinics, and private practices offering subsets of its services [S1].
- Financial snapshot as of 2026-09-30 shows cash and equivalents of $135,212, current assets of $172,823, and current liabilities of $13,675,048, resulting in a current ratio of 0.01 and cash ratio of 0.01, indicating liquidity challenges [S2].
- Net income for the period ending 2026-09-30 was a loss of $10,681,880 with basic and diluted EPS of -$0.32 [S2].
- Revenue data is outdated from 2014 and not representative of current operations [S2].
- The company exited bankruptcy in April 2022 following a reorganization plan confirmed in February 2021, after legal issues involving the former CEO [S1].
- The current CEO, Lance Friedman, was appointed in June 2020 and is the sole board member as of early 2023, with plans to add new board members after a strategic pivot [S1].
- The company emphasizes a personalized, whole-person care approach integrating wellness, anti-aging, and longevity services with primary care support [S1].
- The company’s strategy includes leveraging its compounding pharmacy to enhance patient experience and increase revenue through prescription and over-the-counter sales at attractive margins [S1].
- Financial figures are summarized from the latest available SEC filings and are provided for informational purposes only — not financial advice [S2].
Generated 2026-11-13
- S1 | 2026-03-11 | 10-K
- S2 | 2026-11-13 | 10-Q
- N1 | 2026-11-13 | www.nasdaq.com | ExxonMobil Raised Its Dividend for the 44th Straight Year and Plans $20 Billion of Buybacks in 2027. Here's How It Can Afford Both. | https://www.nasdaq.com/articles/exxonmobil-raised-its-dividend-44th-straight-year-and-plans-20-billion-buybacks-2027-heres
- N2 | 2026-11-13 | www.nasdaq.com | HawkEye 360 (HAWK) Q3 2026 Earnings Call Transcript | https://www.nasdaq.com/articles/hawkeye-360-hawk-q3-2026-earnings-call-transcript
- N3 | 2026-11-13 | www.nasdaq.com | Teekay Tankers Ltd. Reports Third Quarter 2026 GAAP Net Income of $195.2 million | https://www.nasdaq.com/articles/teekay-tankers-ltd-reports-third-quarter-2026-gaap-net-income-1952-million
- N4 | 2026-11-13 | www.nasdaq.com | First Community Bankshares, Inc. Corrects Voting Outcome of Proposal 4 at 2025 Annual Meeting | https://www.nasdaq.com/articles/first-community-bankshares-inc-corrects-voting-outcome-proposal-4-2025-annual-meeting
- N5 | 2026-11-13 | www.nasdaq.com | Amtech Systems, Inc. Increases Annual Base Salary of CEO Guy Shechter to $450,000 | https://www.nasdaq.com/articles/amtech-systems-inc-increases-annual-base-salary-ceo-guy-shechter-450000
- N6 | 2026-11-13 | www.nasdaq.com | Analysts Expect 14% Gains Ahead For The Holdings of AESR | https://www.nasdaq.com/articles/analysts-expect-14-gains-ahead-holdings-aesr
- N7 | 2026-11-13 | www.nasdaq.com | Regional Health Properties, Inc. Reports Results of 2026 Annual Meeting of Shareholders | https://www.nasdaq.com/articles/regional-health-properties-inc-reports-results-2026-annual-meeting-shareholders
- N8 | 2026-11-13 | www.nasdaq.com | CAE Inc. Launches Consent and Proxy Solicitation for $400 million of 5.541% Series 1 Senior Unsecured Notes | https://www.nasdaq.com/articles/cae-inc-launches-consent-and-proxy-solicitation-400-million-5541-series-1-senior-unsecured
This material is for informational purposes only and does not constitute investment, financial, legal or tax advice, or an offer or solicitation to buy or sell any security. The Valye AI Score is a model-based estimate derived from public information and is subject to change without notice. No representation or warranty, express or implied, is made as to the accuracy, completeness or fairness of the information herein. Past performance is not indicative of future results. Investors should conduct their own research and consult a qualified financial adviser before making any investment decisions.

Generated by Valye SEC Pipeline Engine
.gif)


